Related Experiment Video
Updated: Aug 6, 2026

10:25
Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
Published on: September 25, 2019
A large-scale comparative study of YOLO-based detectors for ischemic stroke lesion localization on diffusion-weighted
Suat Ince1, Bilal Bayram2, Hamidullah Turkmen3
1Department of Radiology, University of Health Sciences, Van Education and Research Hospital, 65300 Van, Turkey.
Neuroscience
|July 23, 2026
Summary
Accurately localizing ischemic stroke lesions on diffusion-weighted imaging (DWI) is challenging. This study benchmarks YOLO-based detectors, finding YOLO26x offers the best localization, while YOLO26s balances accuracy and efficiency.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Neurology
Background:
- Ischemic stroke lesion detection on diffusion-weighted imaging (DWI) is difficult due to lesion characteristics like small size, faintness, irregularity, or multiplicity.
- Accurate localization of these lesions is crucial for timely diagnosis and treatment.
Purpose of the Study:
- To provide a controlled, lesion-level benchmark of recent YOLO-based object detection models for localizing ischemic stroke lesions on DWI.
- To compare the performance of various YOLO detector configurations under a unified evaluation protocol.
Main Methods:
- A private clinical dataset of 300 patients with approximately 2,200 DWI images was used, with expert-annotated bounding boxes for lesions.
- Twenty-four YOLO detector configurations (YOLOv10, YOLO11, YOLO12, YOLO13, YOLO26) were trained and evaluated using standardized transfer learning, augmentation, and patient-level partitioning.
- Performance metrics included precision, recall, mAP@50, mAP@50-95, inference time, parameter count, GFLOPs, and bootstrap confidence intervals.
Main Results:
- YOLO26x achieved the highest strict-localization accuracy (0.8287 precision, 0.6867 recall, 0.7940 mAP@50, 0.5094 mAP@50-95).
- YOLO11x showed the highest precision, while YOLO12x demonstrated the highest recall.
- YOLO26s offered a favorable accuracy-efficiency balance with comparable mAP@50-95 at a lower computational cost.
- Overlapping bootstrap confidence intervals suggest caution when interpreting small performance differences between top detectors.
Conclusions:
- The study offers a clinically relevant comparison of YOLO-based detectors for DWI ischemic stroke lesion localization.
- Detector selection should balance strict localization accuracy with computational efficiency for optimal clinical application.